Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 886982 NEW YORK, NY
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$154,676,332
+$54,684,020 QoQ
Shares Held
22,713,118
+1.5% QoQ
Ownership
6.97%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 208 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. TSHA ranks #15 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in TSHA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $154,676,332 22,713,118
2026-03-31 $99,992,312 22,369,645
2025-12-31 $75,310,064 13,692,739
2025-09-30 $43,764,724 13,383,708
2025-06-30 $29,077,586 12,587,700
2025-03-31 $499,019 359,007
2024-12-31 $1,673,158 967,144
2024-09-30 $2,423,398 1,205,671
2024-06-30 $2,300,518 1,027,018
2024-03-31 $3,039,220 1,058,962
2023-12-31 $147,748 83,474
2022-12-31 $27,407 12,127
2022-09-30 $83,921 43,483
2022-06-30 $257,717 69,279
2022-03-31 $580,533 89,039
2021-12-31 $618,008 53,048
2021-09-30 $225,283 12,099
2020-12-31 $391,810 14,763
2020-09-30 $1,761,200 78,625